Financial reports
10-Q
2023 Q3
Quarterly report
9 May 23
10-K/A
2022 FY
Annual report (amended)
28 Apr 23
10-K
2022 FY
Annual report
28 Feb 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
9 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
10-Q
2021 Q2
Quarterly report
11 Aug 21
10-Q
2021 Q1
Quarterly report
13 May 21
Current reports
8-K
Completion of Acquisition or Disposition of Assets
16 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 23
8-K
Other Events
23 May 23
8-K
Prometheus Biosciences Reports First Quarter 2023 Financial Results and Highlights Recent Corporate Progress
9 May 23
8-K
Entry into a Material Definitive Agreement
17 Apr 23
8-K
Regulation FD Disclosure
10 Mar 23
8-K
Prometheus Biosciences Reports Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Corporate Progress
28 Feb 23
8-K
Prometheus Biosciences, Inc. Announces Proposed Public Offering of Common Stock
9 Dec 22
8-K
Other Events
7 Dec 22
8-K
Prometheus Biosciences Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress
9 Nov 22
Registration and prospectus
15-12G
Securities registration termination
27 Jun 23
25-NSE
Exchange delisting
16 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Jun 23
POSASR
Automatic shelf registration (post-effective amendment)
16 Jun 23
S-8
Registration of securities for employees
28 Feb 23
424B5
Prospectus supplement for primary offering
9 Dec 22
424B5
Prospectus supplement for primary offering
7 Dec 22
S-3ASR
Automatic shelf registration
1 Apr 22
S-8
Registration of securities for employees
15 Mar 21
Proxies
DEFA14A
Additional proxy soliciting materials
6 Jun 23
DEFA14A
Additional proxy soliciting materials
23 May 23
DEFM14A
Proxy related to merger
16 May 23
PREM14A
Preliminary proxy related to merger
28 Apr 23
DEFA14A
Additional proxy soliciting materials
17 Apr 23
DEFA14A
Additional proxy soliciting materials
1 Apr 22
DEF 14A
Definitive proxy
1 Apr 22
Other
EFFECT
Notice of effectiveness
12 Mar 21
SEC STAFF
SEC staff action: Order
11 Mar 21
CERT
Certification of approval for exchange listing
10 Mar 21
CORRESP
Correspondence with SEC
9 Mar 21
CORRESP
Correspondence with SEC
9 Mar 21
CORRESP
Correspondence with SEC
8 Mar 21
UPLOAD
Letter from SEC
3 Mar 21
SEC STAFF
SEC staff action: Order
1 Mar 21
CORRESP
Correspondence with SEC
19 Feb 21
UPLOAD
Letter from SEC
11 Feb 21